相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Methodological Aspects of Meta-Analyses Assessing the Effect of Blood Pressure-Lowering Treatment on Clinical Outcomes
Mattias Brunstrom et al.
HYPERTENSION (2022)
Sympathetic Neural Mechanisms Underlying Attended and Unattended Blood Pressure Measurement
Guido Grassi et al.
HYPERTENSION (2021)
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants
Jackie Bosch et al.
EUROPEAN HEART JOURNAL (2021)
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure. An individual participant-level data meta-analysis
Denis Pouchain
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2021)
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
Frank L. J. Visseren et al.
EUROPEAN HEART JOURNAL (2021)
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis
Kazem Rahimi et al.
LANCET (2021)
Time to remove hypertension from our vocabulary?
Rod Jackson et al.
LANCET (2021)
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants
Jackie Bosch et al.
EUROPEAN HEART JOURNAL (2021)
The muddy waters of the J-curve and coronary revascularization
Franz H. Messerli et al.
EUROPEAN HEART JOURNAL (2020)
Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trial
Michael Boehm et al.
EUROPEAN HEART JOURNAL (2020)
2020 International Society of Hypertension global hypertension practice guidelines
Thomas Unger et al.
JOURNAL OF HYPERTENSION (2020)
Concordance Between Blood Pressure in the Systolic Blood Pressure Intervention Trial and in Routine Clinical Practice
Paul E. Drawz et al.
JAMA INTERNAL MEDICINE (2020)
Control of blood pressure and risk of mortality in a cohort of older adults: the Berlin Initiative Study
Antonios Douros et al.
EUROPEAN HEART JOURNAL (2019)
Benefits and harms of lower blood pressure treatment targets: systematic review and meta-analysis of randomised placebo-controlled trials
Mattias Brunstrom et al.
BMJ OPEN (2019)
Unattended automated office vs. ambulatory blood pressure in people with high cardiovascular risk: implications for understanding the SPRINT results
Sverre E. Kjeldsen et al.
JOURNAL OF HYPERTENSION (2019)
Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials
Michael Boehm et al.
EUROPEAN HEART JOURNAL (2018)
Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial)
Brian P. Shapiro et al.
HYPERTENSION (2018)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/N MA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels A Systematic Review and Meta-analysis
Mattias Brunstrom et al.
JAMA INTERNAL MEDICINE (2018)
Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials
Michael Boehm et al.
LANCET (2017)
Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial
Giuseppe Mancia et al.
EUROPEAN HEART JOURNAL (2016)
Effects of blood pressure lowering treatment in hypertension: 8. Outcome reductions vs. discontinuations because of adverse drug events - meta-analyses of randomized trials
Costas Thomopoulos et al.
JOURNAL OF HYPERTENSION (2016)
Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes
Yoichiro Hirakawa et al.
JOURNAL OF HYPERTENSION (2016)
Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study
Emmanuelle Vidal-Petiot et al.
LANCET (2016)
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
Dena Ettehad et al.
LANCET (2016)
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease
Eva M. Lonn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Effects of Blood Pressure Reduction in Mild Hypertension A Systematic Review and Meta-analysis
Johan Sundstrom et al.
ANNALS OF INTERNAL MEDICINE (2015)
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
Jackson T. Wright et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
2014 Evidence-based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) (vol 311, pg 507, 2014)
P. A. James
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
What do we know about the risks of stopping antihypertensive treatment?
Bo Carlberg
JOURNAL OF HYPERTENSION (2014)
Subgroup and per-protocol analyses from the Hypertension in the Very Elderly Trial
Nigel Beckett et al.
JOURNAL OF HYPERTENSION (2014)
Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials
Costas Thomopoulos et al.
JOURNAL OF HYPERTENSION (2014)
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)
Paul A. James et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Systolic Blood Pressure and Cardiovascular Outcomes During Treatment of Hypertension
Michael A. Weber et al.
AMERICAN JOURNAL OF MEDICINE (2013)
Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial
O. R. Benavente et al.
LANCET (2013)
Safety and Efficacy of Low Blood Pressures Among Patients With Diabetes Subgroup Analyses From the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial)
Josep Redon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
Hermann Haller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events
John J. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Principal Results of the Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS)
JATOS Study Group
HYPERTENSION RESEARCH (2009)
Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery
Jean L. Rouleau et al.
CIRCULATION (2008)
Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients
Kenneth Jamerson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Dogma disputed: Can aggressively hypertensive patients with coronary artery lowering blood pressure in disease be dangerous?
Franz H. Messerli et al.
ANNALS OF INTERNAL MEDICINE (2006)
The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients
LS Liu et al.
JOURNAL OF HYPERTENSION (2005)
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial):: randomised controlled trial
PA Poole-Wilson et al.
LANCET (2004)